<DOC>
	<DOC>NCT01649453</DOC>
	<brief_summary>The study prospectively assesses the change in cancer-specific clinical decisions and outcomes before and after physicians received results from the Pathwork® Tissue of Origin (TOO) Test for patients whose primary site of cancer origin is uncertain.</brief_summary>
	<brief_title>A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and December 2013 the patient is ≥ 18 years of age the patient has given informed consent (online or verbal) the patient is able to understand English.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Neoplasms</keyword>
	<keyword>Neoplasm Metastasis</keyword>
	<keyword>Neoplastic Processes</keyword>
	<keyword>Pathologic Processes</keyword>
</DOC>